| Trial ID: | L0974 |
| Source ID: | NCT00179205
|
| Associated Drug: |
Nepro Nutritional Supplement
|
| Title: |
Complementary Intradialytic Nutritional Supplementation in Dialysis Patients
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease
|
| Interventions: |
DRUG: Nepro nutritional supplement|DRUG: placebo
|
| Outcome Measures: |
Primary: increase in serum albumin, 6 months | Secondary: increase in lean body mass, 6 months
|
| Sponsor/Collaborators: |
Sponsor: Vanderbilt University | Collaborators: Ross Laboratories
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
27
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-05
|
| Completion Date: |
2007-12
|
| Results First Posted: |
|
| Last Update Posted: |
2008-08-06
|
| Locations: |
Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00179205
|
